Deciphera Pharmaceuticals Nachrichten und Aktivitäten
Präsenz
ONO Pharmaceutical ist einer der ...
ONO Pharmaceutical ist ein Unternehmen, das unter dem Börsenticker 4528 (JP) gelistet ist.
ONO Pharmaceutical hat eine direkte Präsenz in 2 Ländern.
Fusion, Akquisition und Finanzierung mit ONO Pharmaceutical.
Führungskräfte
Siehe das Organigramm mit seine 13 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei Deciphera Pharmaceuticals
- Ryota Udagawa, Chief Executive Officer and President
- Toichi Takino, Director
- Masayuki Tanigawa, Director
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Deciphera Pharmaceuticals nachzuverfolgen.
Pharmazie
ONO Pharmaceutical hat 1.834 Konkurrenten , einschließlich Pfizer (USA), Sanofi (Frankreich) und Eli Lilly (USA).
Popular M&A news in Pharmazie
- Imbria Pharmaceuticals hat gerade eine Spendenaktion von 58 Millionen Dollar angekündigt. (veröffentlicht am 10, April 2025).
- Clario hat NRx Pharmaceuticals erworben (veröffentlicht am 18, März 2025).
- Knight Therapeutics has announced the acquisition of Paladin Labs (veröffentlicht am 12, März 2025).
Andere vorgeschlagene Kontakte der Pharmazie branche
Nachrichten
Neueste Pressemitteilungen nach Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- View more press releases Close
Social media about Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals auf Wikipedia, Google News & Yahoo Finance
- Deciphera Pharmaceuticals auf LinkedIn, Twitter & YouTube
